Cargando…

CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma

BACKGROUND: CD133 is known to be a cancer stem cell (CSC) marker. However, recent studies have revealed that CD133 is not restricted to CSC but to be expressed not only in human normal tissues but also in some cancers and could serve as a prognostic factor for the patients. Nevertheless, the express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Linni, He, Furong, Liu, Hongxiang, Zhu, Jin, Liu, Yixiong, Yin, Zhiyong, Wang, Lu, Guo, Ying, Wang, Zhe, Yan, Qingguo, Huang, Gaosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161038/ https://www.ncbi.nlm.nih.gov/pubmed/21798073 http://dx.doi.org/10.1186/1471-2407-11-320

Ejemplares similares

The possible role of ribosomal protein S6 kinase 4 in the senescence of endothelial progenitor cells in diabetes mellitus
por: Yin, Zhiyong, et al.
Publicado: (2012)

Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma
por: Wei, Jie, et al.
Publicado: (2022)

MicroRNA-142-5p contributes to Hashimoto’s thyroiditis by targeting CLDN1
por: Zhu, Jin, et al.
Publicado: (2016)

EWSR1::SMAD3-rearranged fibroblastic tumor: A case with twice recurrence and literature review
por: Yang, Li, et al.
Publicado: (2022)

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
por: Cai, Xiaobo, et al.
Publicado: (2018)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
por: Ma, Jing, et al.
Publicado: (2020)

Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma
por: Xu, Tianqi, et al.
Publicado: (2019)

Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
por: Chen, Lang, et al.
Publicado: (2020)

Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy
por: Lv, Yang, et al.
Publicado: (2015)

Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss
por: Li, Xia, et al.
Publicado: (2017)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
por: LU, CANRONG, et al.
Publicado: (2013)

Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
por: Sangsuwannukul, Thanich, et al.
Publicado: (2022)

Bioinformatics Analysis of Inflammation Gene Signature in Indicating Cholangiocarcinoma Prognosis
por: Wang, Yanting, et al.
Publicado: (2022)

Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
por: Feng, Kai-chao, et al.
Publicado: (2017)

BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis
por: Zeng, Kaixuan, et al.
Publicado: (2016)

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021)

CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chen, Shicai, et al.
Publicado: (2013)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer
por: Liu, Wan-Ting, et al.
Publicado: (2019)

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
por: Ma, Shirong, et al.
Publicado: (2018)

Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival
por: Zhang, Qingping, et al.
Publicado: (2019)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
por: Park, Youn Young, et al.
Publicado: (2019)

An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma
por: Joyce, Thomas, et al.
Publicado: (2023)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
por: Chen, Yao-Li, et al.
Publicado: (2017)

CD86(+)/CD206(+) tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
por: Sun, Dalong, et al.
Publicado: (2020)

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma
por: Liang, Zhanqiang, et al.
Publicado: (2019)

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line
por: HAN, YONG, et al.
Publicado: (2015)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

IL23R as an indicator of immune infiltration and poor prognosis in intrahepatic cholangiocarcinoma: a bioinformatics analysis
por: Zhang, Lin-Ting, et al.
Publicado: (2023)

Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
por: Hashimoto, Kousuke, et al.
Publicado: (2013)

Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
por: Pradhan, Tapas, et al.
Publicado: (2019)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2014)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ukrq3rs7f555l59s23gvmp0ree